10 recruiting, 1 not yet recruiting. 10 Phase 2, 6 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Recruiting 10 |
| Phase 1 | 6 | Recruiting 6 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow LBL-024 for Injection: new trials by email Literature Review of LBL-024 for Injection trials Research Report on LBL-024 for Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC LBL-024 for Injection, Etoposide injection, Cisplatin injection - Advanced Extrapulmonary Neuroendocrine Carcinoma | Phase 3 | Not yet recruiting | Nanjing Leads Biolabs Co.,Ltd | 280 | 2026-11-16 | 2026-10-19 |
| A Clinical Trial of LBL-024 Combination Drug in Patients With Metastatic Colorectal Carcinoma LBL-024 for Injection, Bevacizumab injection, Oxaliplatin injection - Metastatic Colorectal Carcinoma | Phase 1 / Phase 2 | Recruiting | Nanjing Leads Biolabs Co.,Ltd | 369 | 2026-09-28 | 2026-10-16 |
| A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04] LBL-024 for Injection, Capecitabine tablets, Tislelizumab Injection - Advanced Solid Tumour | Phase 2 | Recruiting | Nanjing Leads Biolabs Co.,Ltd | 110 | 2026-04-13 | 2026-05-13 |
| A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)] LBL-024 for Injection, Cisplatin Injection, Paclitaxel Injection - Advanced Solid Tumour | Phase 2 | Recruiting | Nanjing Leads Biolabs Co.,Ltd | 110 | 2026-02-26 | 2026-05-18 |
| A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer LBL-024 for Injection, albumin-bound Paclitaxel injection, Toripalimab Injection - Triple Negative Breast Cancer | Phase 1 / Phase 2 | Recruiting | Nanjing Leads Biolabs Co.,Ltd | 220 | 2026-01-27 | 2026-02-12 |
| A Study of LBL-024 in Combination With Paclitaxel ± Bevacizumab for the Treatment of Platinum-resistant Ovarian Cancer LBL-024 for Injection, Paclitaxel injection, Bevacizumab injection - Ovarian Cancer | Phase 1 / Phase 2 | Recruiting | Nanjing Leads Biolabs Co.,Ltd | 180 | 2025-12-02 | 2026-08-13 |
| A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)] LBL-024 for Injection, Cisplatin Injection, Gemcitabine Hydrochloride for Injection - Advanced Solid Tumour | Phase 2 | Recruiting | Nanjing Leads Biolabs Co.,Ltd | 140 | 2025-10-20 | 2026-10-19 |
| A Trial of LBL-024 Monotherapy or Combination With Toripalimab in Patients With Advanced Melanoma. LBL-024 for Injection, Toripalimab Injection - Advanced Melanoma | Phase 1 / Phase 2 | Recruiting | Nanjing Leads Biolabs Co.,Ltd | 280 | 2025-09-05 | 2026-10-21 |
| A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)] LBL-024 for Injection, Docetaxel Injection, Bevacizumab Injection - Advanced Solid Tumour | Phase 2 | Recruiting | Nanjing Leads Biolabs Co.,Ltd | 250 | 2025-06-11 | 2026-08-27 |
| A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma LBL-024 for Injection, Etoposide Injection, Carboplatin Injection - Advanced Neuroendocrine Carcinoma | Phase 1 / Phase 2 | Recruiting | Nanjing Leads Biolabs Co.,Ltd | 178 | 2023-12-08 | 2026-03-12 |
| A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors LBL-024 for Injection - Advanced Solid Tumor | Phase 1 / Phase 2 | Recruiting | Nanjing Leads Biolabs Co.,Ltd | 396 | 2022-01-06 | 2026-06-30 |
Colorectal Neoplasms (1) · Ovarian Neoplasms (1) · Triple Negative Breast Neoplasms (1)
Nanjing Leads Biolabs Co.,Ltd (11)
China (11)